Abstract: Automated web application testing is a critical component of modern software development, with frameworks like Selenium widely adopted for validating functionality through browser automation ...

We are now a few years into the AI revolution, and talk has shifted from who has the best chatbot to whose AI agent can do the most things on your behalf. Unfortunately, AI agents are still rough ...

OpenAI confirmed it's testing ads in ChatGPT for U.S. users on free and Go tiers. Ads appear at the bottom of responses, labeled as sponsored. Paid tiers including Plus, Pro, Business, Enterprise, and ...

The US Environmental Protection Agency is accelerating its shift away from testing certain chemicals on animals as it reinstitutes a 2035 deadline that President Joe Biden’s administration scrapped in ...

Threat actors are exploiting misconfigured web applications used for security training and internal penetration testing, such as DVWA, OWASP Juice Shop, Hackazon, and bWAPP, to gain access to cloud ...

OpenAI plans to test ads for ChatGPT Free and Go users in the U.S., while keeping Pro, Business, and Enterprise plans ad-free. Ads will appear below responses, remain clearly labeled, and will not ...

In a new experiment, Meta is limiting the number of links users can post on Facebook, unless they have a paid Meta Verified subscription. According to the screenshot posted by Navarra, users can still ...

Google is updating the links in AI Mode to make them more inviting to click. Google also expanded the Web Guides Labs test to the All tab, though you still need to opt in to try it. Links in AI Mode.

Ran Ronen, Founder and CEO of Equally AI, simplifying web accessibility to ensure compliance with ADA, EAA and WCAG standards. By mid-2025, ADA web accessibility lawsuits had increased by 37% compared ...

Let’s be honest. Most teams don’t think about accessibility testing until someone flags an issue, usually right before release or right after a user complaint. That’s when you scramble to check labels ...

Colorectal cancer (CRC) remains a major global health challenge, with limited immunotherapy efficacy in microsatellite stable (MSS) tumors that comprise ~85% of cases. The p53 tumor suppressor pathway ...